Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.
Press releases published on May 5, 2025
Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
GlobeNewswire
·
May 5, 2025
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …
Sagitec Awarded MainePERS Project for a Modern Pension Administration System
GlobeNewswire
·
May 5, 2025
ST. PAUL, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sagitec is proud to announce that it has been awarded the Maine Public Employees Retirement System (MainePERS) project. This achievement is a testament to Sagitec's commitment to adhering to the vision that …
GraniteShares ETFs Announces Change to the Investment Objective on one of its Inverse Leveraged ETFs
GlobeNewswire
·
May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- As announced on March 05, 2025 the investment strategy for the GraniteShares 1x Short COIN Daily ETF (ticker: CONI) will be amended and result in a new fund name and a new leverage factor. Effective May 05, 2025, …
Werewolf Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 5, 2025
WATERTOWN, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
GlobeNewswire
·
May 5, 2025
Improvements in subjective and objective measures of efficacy observed at six months persisted for one year in patients with severe vision impairment from inherited retinal degeneration due to mutations in the LCA5 gene Administration of OPGx-LCA5 by …
Healthy Choice Wellness Corp. Completes Second Tranche of Debt-for-Equity Conversion
GlobeNewswire
·
May 5, 2025
HOLLYWOOD, FL, May 05, 2025 (GLOBE NEWSWIRE) -- Healthy Choice Wellness Corp. (NYSEAM: HCWC) today announced that it has further strengthened its balance sheet through the conversion of approximately $400,000 in outstanding debt into shares of the Company’ …
IDI Integrates with Ping Identity’s PingOne DaVinci to Deliver Powerful Identity Insights Across the Consumer Journey
GlobeNewswire
·
May 5, 2025
BOCA RATON, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- Interactive Data, LLC (“IDI”), a red violet company (NASDAQ: RDVT) and leader in identity verification and risk mitigation, today announced a new integration with Ping Identity, a leader in securing …
LPL Financial Welcomes Northern Advisory Group
GlobeNewswire
·
May 5, 2025
SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that 10 financial advisors with Northern Advisory Group have joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) and custodial platforms. They reported …
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025
GlobeNewswire
·
May 5, 2025
LAWRENCEVILLE, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a conference call at 11:00 a.m. ET on Monday, …
MediWound to Report First Quarter 2025 Financial Results
GlobeNewswire
·
May 5, 2025
YAVNE, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will report financial results for the first quarter ended March 31, 2025 on …
Study Shows Large Improvements in Long COVID Symptoms and Return to Work
GlobeNewswire
·
May 5, 2025
SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized controlled trial to show large and very large improvements in …
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
GlobeNewswire
·
May 5, 2025
Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting as Recommended by Leading Independent Proxy Advisory Firms SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today issued the …
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
GlobeNewswire
·
May 5, 2025
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX , May 05, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the …
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event
GlobeNewswire
·
May 5, 2025
BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1
GlobeNewswire
·
May 5, 2025
Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS <1 Mature overall survival data builds on encouraging high response rates with multiple complete …
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis
GlobeNewswire
·
May 5, 2025
Ramat Gan, Israel, May 05, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced that …
Sell Fast Chicagoland: Home Cash Buyers in Chicago Celebrate 20 Years of Delivering Swift Property Solutions
GlobeNewswire
·
May 5, 2025
Glenview, IL, May 05, 2025 (GLOBE NEWSWIRE) -- Sell Fast Chicagoland, a leading cash home buyer specializing in fast, hassle-free home sales, is excited to announce the celebration of serving its local community with over 20 years of swift property …
Voreifarem Partners with SwfcNrho Exchange to Create a Global New Paradigm for Medical Data Valuation
GlobeNewswire
·
May 5, 2025
New York, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Recently, Voreifarem, the world’s first digital health project built on the core architecture of "medical chips + blockchain" (token abbreviation: IER), officially launched on the international mainstream …
Valueex (VUEE) Exchange Opens IEO Window, Leading New Opportunities in Global Blockchain Investment
GlobeNewswire
·
May 5, 2025
Fresno, CA, May 05, 2025 (GLOBE NEWSWIRE) -- In an era where blockchain technology and digital assets are rapidly rising, Initial Exchange Offerings (IEOs) have become an important avenue for investors to engage with emerging projects. Valueex Exchange ( …
Super Clone Watch Market 2024: Replicawrist’s Latest Industry Overview
GlobeNewswire
·
May 5, 2025
SAUKVILLE, Wis., May 05, 2025 (GLOBE NEWSWIRE) -- For years, luxury watches have stood as the pinnacle of status—symbolizing sophistication, craftsmanship, and influence. However, as the appetite for premium timepieces hits unprecedented levels, an …